Keith Katkin

(Mr. Keith Katkin CPA)

Currently holds a position at Syndax Pharmaceuticals Inc

Positions

Position Company Period
Independent Director Syndax Pharmaceuticals Inc March 29, 2017 -
Keith Katkin's trades of Emergent BioSolutions Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-05-28 2025-05-23
PS Planned sale
7,844 -8.3%
6.30
USD 49,417 		7,844 -8.3% 6.30 USD 49,417
2025-05-19 2025-05-19
B Purchase
10,000 +11.1%
9.11
USD 91,120 		10,000 +11.1% 9.11 USD 91,120
2022-10-07 2022-10-06
PS Planned sale
9,117 -22.2%
25.90
USD 236,139 		9,117 -22.2% 25.90 USD 236,139
2022-10-07 2022-10-06
PS Planned sale
20,782 -39.4%
25.90
USD 538,273 		20,782 -39.4% 25.90 USD 538,273
2022-10-04 2022-10-04
PS Planned sale
223 -0.7%
25.00
USD 5,575 		223 -0.7% 25.00 USD 5,575
2022-10-04 2022-10-04
PS Planned sale
137 -0.4%
25.00
USD 3,425 		137 -0.4% 25.00 USD 3,425
2022-10-04 2022-10-03
PS Planned sale
13 -0.0%
25.00
USD 325 		13 -0.0% 25.00 USD 325
2022-10-04 2022-10-03
PS Planned sale
167 -0.5%
25.00
USD 4,175 		167 -0.5% 25.00 USD 4,175
2022-10-04 2022-09-30
PS Planned sale
647 -2.0%
25.07
USD 16,221 		647 -2.0% 25.07 USD 16,221
2022-10-04 2022-09-30
PS Planned sale
2,914 -8.3%
25.07
USD 73,056 		2,914 -8.3% 25.07 USD 73,056
// ... existing code ...